基于移动端干预的冠状动脉旁路移植术后糖尿病患者血糖控制:随机对照试验研究方案
GUIDE ME研究是一项在中国2家医院开展的多中心随机对照试验,评估基于微信小程序的教育与提醒系统对冠状动脉旁路移植术后糖尿病患者血糖控制及二级预防的效果与可行性,计划纳入820例患者,随访6个月,主要结局为6个月时糖化血红蛋白(HbA1c)的变化。
要点
- 干预组在标准治疗基础上接受180条含台词的二级预防教育视频及用药提醒,为期6个月。
- 主要结局为6个月时HbA1c变化,次要结局包括HbA1c达标比例、空腹血糖、收缩压、LDL-C及服药依从性变化。
- 该试验为首次研究基于微信视频 coaching 与用药提醒小程序在CABG术后糖尿病合并冠心病患者自我管理中的效果。
核心结论
- 该试验旨在评估基于移动端的 coaching 干预改善CABG术后糖尿病患者危险因素控制和二级预防的有效性与可行性。
- 若成功,此类移动干预可用于并推广至该高危患者群体的照护。
研究设计与样本
- 多中心随机对照试验,比较移动干预与标准治疗,随访6个月,在中国2家医院开展。
- 计划总样本量为820例患者。
- 干预组在标准治疗基础上接受基于微信小程序的180条含台词视频的二级预防教育及提醒系统,为期6个月,并采用行为改变技术如提示障碍识别、动机技巧和目标设定。
主要发现
- 原文为研究方案,未报告结果数据。
关键数值与推荐
- 主要结局为6个月时糖化血红蛋白(HbA1c)的变化。
- 次要结局包括HbA1c达标比例、空腹血糖、收缩压、低密度脂蛋白胆固醇(LDL-C)及服药依从性的变化。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Applying technology through the use of the Internet and mobile phones can help provide education and trained peer support for patients with diabetes after coronary artery bypass (CABG). We are conducting a randomized controlled trial to evaluate the efficacy and feasibility of mobile-based coaching intervention in improving risk-factor control and secondary prevention in patients with diabetes after CABG. METHODS: The glycaemic control using miniprogram-based intervention in patients with diabetes undergoing coronary artery bypass to promote self-management (GUIDE ME) study is a multi-centre, randomized controlled trial of mobile intervention versus standard treatment with 6 months follow-up conducted in 2 hospitals in China. The interventions are education and a reminder system based on the WeChat mini-program. Participants in the intervention groups receive 180 videos (including lines) about secondary prevention education for 6 months as well as the standard treatment. Behavioural change techniques, such as prompting barrier identification, motivational skills, and goal setting, are employed. A total sample size of 820 patients would be adequate for the GUIDE ME study. The primary outcome is the change of glycaemic haemoglobin (HbA1c) at 6 months. Secondary outcomes include a change in the proportions of patients achieving HbA1c, fasting blood glucose, systolic blood pressure, low-density lipoprotein cholesterol (LDL-C) and medication adherence. DISCUSSION: This trial is the first to investigate the efficacy of mobile phone WeChat-based video coaching and medication reminder mini-program system to improve self-management in patients with diabetes and coronary heart disease (CHD) after CABG and has the potential to be applied in resource-limited settings across diverse populations. If successful, such mobile intervention could be used and scaled up to improve care for this high-risk group of patients. TRIAL REGISTRATION: ClinicalTrials, NCT04192409 . Registered on December 10, 2019.
引用
- Song Y, Nan Y, Feng W, et al. Glycaemic control using mobile-based intervention in patients with diabetes undergoing coronary artery bypass-study protocol for a randomized controlled trial. Trials. 2023. PMID: 37705074. doi:10.1186/s13063-023-07580-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。